Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cabaletta Bio, Inc. - Common Stock
(NQ:
CABA
)
2.270
+0.080 (+3.65%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cabaletta Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
↗
January 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 20, 2023
Via
Benzinga
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
January 09, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
↗
December 23, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 08, 2022
Via
Benzinga
Cabaletta Bio Announces $35 Million Offering
December 08, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 22, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
↗
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
↗
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 14, 2022
Gainers
Via
Benzinga
Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket
↗
November 14, 2022
Via
Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
↗
November 11, 2022
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are...
Via
Benzinga
Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Cabaletta Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 07, 2022
Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings...
Via
Benzinga
US Stocks Turn Lower; Dow Tumbles Over 100 Points
↗
October 20, 2022
U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping more than 100 points on Thursday.
Via
Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
↗
November 04, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
↗
November 02, 2022
Gainers
Via
Benzinga
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
↗
October 21, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 20, 2022
Gainers
Via
Benzinga
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
↗
October 20, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
Via
Benzinga
$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
↗
October 20, 2022
The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
↗
October 20, 2022
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 19, 2022
Gainers
Via
Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
↗
October 19, 2022
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 18, 2022
Gainers
Via
Benzinga
Week In Review: Jemicare Out-Licenses Prostate Cancer Therapy To Roche For $650 Million
↗
October 15, 2022
Deals, financings, trials and approvals on the China biotech/pharma market.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
